Search

Your search keyword '"Robert P. Whitehead"' showing total 404 results

Search Constraints

Start Over You searched for: Author "Robert P. Whitehead" Remove constraint Author: "Robert P. Whitehead"
404 results on '"Robert P. Whitehead"'

Search Results

1. The effects of disease lesions and amoxicillin treatment on the physiology of SCTLD-affected corals

2. Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

3. Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

4. Macroalgae has no effect on the severity and dynamics of Caribbean yellow band disease.

5. Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors

6. Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWO

7. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)

8. Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

9. Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

10. A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

11. A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

12. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy

13. Abstract CT134: Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

15. Phase II Trial of CI-980 in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – A Southwest Oncology Group Study

16. Relationship Between Activated Protein C Resistance and Central Venous Device-Related Complications

17. A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

18. Abstract 3138: Changes in tumor cell-free DNA copy number instability (CNI) predict therapeutic response in metastatic cancers

19. A Phase II Trial of Concomitant Human Interleukin-2 and Interferon-??-2a in Patients with Disseminated Malignant Melanoma

20. HIES

21. Hereditary Motor and Sensory Neuropathy

22. Hyperostosis Corticalis Deformans Juvenilis

23. Human Transmissible Spongiform Encephalopathies

24. Hereditary Nephritis

25. Hearing Loss, Noise-induced and Acoustic Trauma

26. Hypersensitivity Type I

27. Hypoglycemia, Non-islet Cell

28. Hyper-IgE Recurrent Infection Syndrome

29. Hypermobility Syndrome

30. Hyperostose en Coulée

31. Hyperekplexia, Hereditary

32. Hand-Heart Syndrome

33. Hyperostosis, Infantile Cortical

34. Hyperparathyroidism, Primary

35. Hypothyroidism, Nongoitrous Congenital

36. β-Hexosaminidase α-Subunit Deficiency

37. Hypoxic Ischemia

38. High Blood Triglycerides

39. Hypersensitivity Vasculitis

40. Hyperthyroidism due to Thyroid Autonomy

41. Hyperhomocysteinemia: Genetic Basis and Arterial Thrombosis

42. Hyperthyroidism, Sporadic Non-autoimmune

43. Hereditary Renal Hypouricemia

44. Huntington’s Chorea

45. Hepatitis, Acute

46. Hauptmann-Thannhauser Muscular Dystrophy

47. High Triglycerides

48. Hemophilia B

49. Human RSV

50. Hypotrichosis-Lymphedema-Telangiectasia Syndrome

Catalog

Books, media, physical & digital resources